Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
TriMas Corp
TRS
$1.4B
| $2.41M | ﹤0.01% |
+137,600
| New | +$2.35M |
|
2102
Ionis Pharmaceuticals
IONS
$9.51B
| $2.41M | ﹤0.01% |
59,400
-75,914
| -56% | -$3.08M |
|
2103
Vicor
VICR
$10.8B
| $2.4M | ﹤0.01% |
229,500
+5,200
| +2% | +$44.8K |
|
|
ALSK
2104
DELISTED
Alaska Communications Systems
ALSK
| $2.4M | ﹤0.01% |
1,351,276
-55,608
| -4% | -$91.8K |
|
2105
Digi International
DGII
$3.23B
| $2.4M | ﹤0.01% |
254,484
-58,331
| -19% | -$532K |
|
|
GSB
2106
DELISTED
GlobalSCAPE, Inc.
GSB
| $2.4M | ﹤0.01% |
631,500
-7,000
| -1% | -$26.2K |
|
2107
Embotelladora Andina Series A
AKO.A
$3.75B
| $2.4M | ﹤0.01% |
141,400
+2,800
| +2% | +$42.9K |
|
|
GCAP
2108
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $2.4M | ﹤0.01% |
365,100
+148,600
| +69% | +$1.03M |
|
|
HDNG
2109
DELISTED
Hardinge Inc
HDNG
| $2.39M | ﹤0.01% |
192,000
+25,100
| +15% | +$237K |
|
|
EJ
2110
DELISTED
E HOUSE (CHINA) HOLDINGS LIMITED
EJ
| $2.39M | ﹤0.01% |
+384,657
| New | +$2.27M |
|
|
GAU
2111
Galiano Gold
GAU
$547M
| $2.39M | ﹤0.01% |
1,122,469
+908,269
| +424% | +$1.67M |
|
2112
Northrim BanCorp
NRIM
$606M
| $2.39M | ﹤0.01% |
399,600
+95,976
| +32% | +$574K |
|
|
RRM
2113
DELISTED
RR MEDIA LTD ORD SHS (ISR)
RRM
| $2.39M | ﹤0.01% |
182,700
+51,750
| +40% | +$527K |
|
2114
MGP Ingredients
MGPI
$379M
| $2.38M | ﹤0.01% |
98,400
-143,600
| -59% | -$3.3M |
|
2115
Travelzoo
TZOO
$73.4M
| $2.38M | ﹤0.01% |
293,200
+30,000
| +11% | +$233K |
|
2116
Grupo Cibest SA
CIB
$22.8B
| $2.38M | ﹤0.01% |
+69,500
| New | +$2.07M |
|
2117
Aware
AWRE
$26.4M
| $2.37M | ﹤0.01% |
636,500
+17,400
| +3% | +$59.4K |
|
2118
Rush Enterprises Class B
RUSHB
$9.37B
| $2.37M | ﹤0.01% |
292,050
-37,575
| -11% | -$302K |
|
2119
Federal Agricultural Mortgage
AGM
$2.53B
| $2.37M | ﹤0.01% |
+62,800
| New | +$2.04M |
|
|
SOL
2120
DELISTED
Emeren Group
SOL
| $2.36M | ﹤0.01% |
328,300
+102,587
| +45% | +$757K |
|
2121
GSI Technology
GSIT
$270M
| $2.36M | ﹤0.01% |
575,900
+63,100
| +12% | +$235K |
|
2122
Liberty Latin America Class A
LILA
$1.69B
| $2.36M | ﹤0.01% |
105,109
+95,894
| +1,041% | +$2.14M |
|
2123
American Vanguard Corp
AVD
$62.5M
| $2.36M | ﹤0.01% |
149,500
+22,346
| +18% | +$292K |
|
2124
Modine Manufacturing
MOD
$11.1B
| $2.36M | ﹤0.01% |
214,100
+49,900
| +30% | +$423K |
|
2125
Genworth Financial
GNW
$3.84B
| $2.35M | ﹤0.01% |
+861,968
| New | +$2.18M |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.